OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 02, 2010
Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.
Global pharmaceutical companies could have a problem getting rid of redundant facilities.
In light of compendial changes, representatives of the US Pharmacopeia and an industry consortium provide perspectives on cap and ferrule labels.
President Obama and HHS eye innovation and countermeasures to protect public health.
October 01, 2010
The development of quality agreements has long been recognised as a critical activity to ensure a product's quality meets regulatory requirements.
The FDA has issued a final rule that clarifies what safety information must be reported during clinical trials of investigational drugs and biologics.
September 30, 2010
Novartis Sells US Enablex Rights; Ricerca Names Chemistry Director; And More.
September 23, 2010
DSM and PolyTherics in Development Deal; Kite Pharma Appoints President and CEO, And More.
September 16, 2010
Genzyme Sells Genetics Business; Bausch and Lomb Names Vice-President; and More.
Last week, Lonza (Basel) agreed to support the ongoing development of GlaxoSmithKline?s (GSK, London) biopharmaceutical pipeline by supplying manufacturing capacity for five early-stage monoclonal antibodies.